Improving neuropsychological diagnostics for cognitive and psychiatric conditions

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This project focuses on enhancing neuropsychological diagnostics by developing and evaluating new psychometric tests for clinical and forensic settings. It aims to create tools that can be administered remotely and assess various cognitive functions in individuals with neurological and psychiatric disorders. The study will involve a sample of neurologically healthy individuals from the Italian population to calibrate these tests and evaluate their effectiveness over time.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Clinical populations: clinical diagnosis of either neurological (e.g., vascular and degenerative aetiologies) or psychiatric disorders.
* Healthy controls: not applicable

Exclusion Criteria:

* Clinical populations:

  1. Clinical diagnosis not of interest;
  2. Severe general medical conditions;
  3. Uncorrected vision/hearing deficits.
* Healthy controls:

  1. Presence of brain disorders;
  2. Severe general medical conditions;
  3. Uncorrected vision/hearing deficits.

Where it's running

• Istituto Auxologico Italiano IRCCS
  Milan, Lombardy, Italy Recruiting

Study contacts

• Study coordinator: Nadia Bolognini, PhD
• Email: n.bolognini@auxologico.it
• Phone: +390261911

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Blood-based tests and digital cognitive checks to help triage dementia

  This study tests whether adding blood biomarkers, APOE4 genetic info, and digital cognitive tests can help dementia diagnosis be faster in NHS Memory Clinics.

  Recruiting at 11 sites Prima Mente · London, Greater London and 11 other locations · NCT07842029

• Blood tests using plasma biomarkers to diagnose and track Alzheimer’s disease

  A large, year-long study in Milan is testing whether blood markers can help diagnose Alzheimer’s and predict how it will progress in people with memory concerns.

  Recruiting IRCCS San Raffaele · Milan, Milano · NCT07717567

• Delirium and cognitive changes in older adults in hospital isolation

  This study tests whether older patients kept in isolation on hospital wards have more delirium or cognitive decline than similar patients not in isolation.

  Recruiting Universitätsklinikum Hamburg-Eppendorf · Hamburg, Free and Hanseatic City of Hamburg · NCT07114458

• Hearing care to reduce neuropsychiatric symptoms in people with Alzheimer's and related dementias

  This trial will try a tailored, community-delivered hearing care program using HEARS devices to see if it improves communication, reduces neuropsychiatric symptoms, and eases caregiver distress in English-speaking older adults with Alzheimer's disease or related dementias who have untreated hearing loss.

  Recruiting Johns Hopkins University · Baltimore, Maryland · NCT06930560

• Community-based study on cognitive impairment in older adults in Hainan

  This study is looking at older adults in Hainan to see what factors affect their thinking skills and to test new tools that might help improve their brain health and physical abilities.

  Recruiting Hainan Medical College · Haikou, Hainan · NCT06686186

• Collecting data on neurodegenerative diseases progression markers

  This study is trying to find new signs that can help doctors understand how neurodegenerative diseases like Parkinson's progress, so they can improve early treatment options for patients.

  Recruiting IRCCS San Raffaele Roma · Cassino, Frosinone · NCT06596746

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.